J&J's consumer health spinout has a new name, Kenvue, and a modern look for its well-known portfolio of brands including Tylenol and Neutrogena.

J&J de­buts Ken­vue as new name for $15B con­sumer health busi­ness spin­off

John­son & John­son’s con­sumer health com­pa­ny has a new name, iden­ti­ty and pur­pose. Ken­vue is a com­bi­na­tion of “ken” mean­ing knowl­edge and “vue” a homonym of view, the com­pa­ny said on Wednes­day.

The $15 bil­lion con­sumer spin­off with house­hold sta­ple brands in­clud­ing Neu­tro­ge­na, Tylenol, Band-Aid and a line­up of ba­by care prod­ucts is set to be­come a sep­a­rate pub­licly trad­ed com­pa­ny by No­vem­ber 2023.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.